Zevra Therapeutics, Inc. (ZVRA) announced Thursday the appointment of Justin Renz as Chief Financial Officer, effective March 9, 2026.
Renz brings more than 25 years of financial leadership experience in the biopharmaceutical industry, including extensive expertise in capital markets, strategic transactions, and commercial-stage operations.
Renz most recently served as Chief Financial & Operations Officer at Ardelyx. Previously, he was President and Chief Financial Officer of Correvio Pharma, a global specialty pharmaceutical company.
Renz also served as Executive Vice President, Chief Financial Officer and Treasurer at Karyopharm Pharmaceuticals and as Executive Vice President and Chief Financial Officer at Zalicus Inc.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.